drugset / Trial / NCT00514007
Study of Continuous OSI-906 Dosing
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Multicenter, open-label, phase 1, cohort dose escalation study to determine the Maximum Tolerated Dose (MTD) on both Once Daily (QD) and Twice Daily (BID) schedules.
Timeline
- Start
- 2007-06-18
- Primary completion
- 2012-03-19
- Completion
- 2012-03-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | linsitinib | Small molecule | — | Oral |